Navigation Links
Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery
Date:2/7/2011

BLUE BELL, Pa., Feb. 7, 2011 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that its new generation DNA vaccine delivery technology, which provides the powerful enabling capabilities of electroporation without contacting the skin, is highlighted in a paper published in the scientific journal Human Vaccines. While current Inovio electroporation devices have been shown to be safe and well-tolerated in multiple human studies, Inovio has been advancing research to achieve the most optimal device characteristics to facilitate mass vaccinations.

Dr. J. Joseph Kim, Inovio's president and CEO, said, "Inovio continues to raise the bar in terms of technological innovation that will further optimize electroporation-based delivery of DNA-based therapeutics and vaccines for patients of all ages. While still enabling levels of vaccine potency that we have observed with our existing electroporation devices, this new contactless delivery method is non-invasive and amenable to the design of devices that are low-cost, portable, and extremely easy to use."

Drug delivery into skin, or dermal tissue, is the most attractive method given that the skin is the largest, most accessible, and most easily monitored organ of the human body, and it is highly immunocompetent (able to recognize antigens and mount an immune response to them). The paper appearing in Human Vaccines, "Piezoelectric permeabilization of mammalian dermal tissue for in vivo DNA delivery leads to enhanced protein expression and increased immunogenicity," authored by Inovio scientists, describes an innovative electroporation method optimized for delivery into skin. This new method is based on piezoelectricity, which is the generation of an electric field or electric potential b
'/>"/>

SOURCE Inovio Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Inovio Pharmaceuticals Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial
2. University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
3. Inovio Pharmaceuticals Closes $24.3 Million Registered Offering
4. Qualitest Pharmaceuticals Issues Voluntary, Nationwide Recall of Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg / 500 mg, NDC 0603-3888-20, 60 Count, Lot Numbers T150G10B, T120J10E and T023M10A and Phenobarbital Tablets, USP 32.4 mg, ND
5. Lotus Pharmaceuticals to Expand Construction of Beijing Facility
6. Quercegen Pharmaceuticals LLC Obtains FDA GRAS Notified Status for its QU995™ Quercetin with Purity Greater than 99.5%
7. Onyx Pharmaceuticals Appoints Bill Ringo to Board of Directors
8. AVANIR Pharmaceuticals Announces Fiscal 2011 First Quarter Financial Results
9. Pacira Pharmaceuticals, Inc. Announces Pricing of Its Initial Public Offering
10. Inspiration Biopharmaceuticals Demonstrates Non-Inferiority of IB1001, Its Recombinant Factor IX for Hemophilia B
11. Dr. Peter Thompson Joins Anthera Pharmaceuticals Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... HARRISBURG, Pa. , Jan. 14, 2014 Dynamic Healthcare ... ("GMH"), announced today that it acquired Progressive Home Medical Equipment, ... January 7, 2014. The terms of the acquisition were not ... medical equipment ("DME") company providing a wide range of sleep, ...
(Date:1/14/2014)... LEESBURG, Va. , Jan. 14, 2014 Animal Emergency Critical ... in Leesburg, Virginia is the first in ... hyperbaric oxygen chamber. Dr. Susan M. Barnes ... years. Dr. Barnes and husband, Dr. Cole Taylor , are ...
(Date:1/14/2014)... NineSigma , Inc., the leading innovation partner to organizations ... May 14-16, 2014 at the Global Center for Health ... This is the premier industry event for ... open innovation. Participants will learn how world-changing innovation is ...
Breaking Medicine Technology:Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 4
... /PRNewswire-FirstCall/ -- Echo Therapeutics, Inc. (OTC ... the needle-free Symphony(TM) tCGM System as a non-invasive, ... the Prelude(TM) SkinPrep System for transdermal drug delivery, ... to the development of its needle-free Symphony tCGM ...
... MILAN, October 29 Mirial has just released ... which explains in details the benefits of Telehealth and ... , Widening the original scope ... Telehealth is meant to support also the preventive,and promotive ...
Cached Medicine Technology:Echo Therapeutics Announces Significant Advance in Development of its One-Piece, Needle Free Symphony tCGM Biosensor 2Echo Therapeutics Announces Significant Advance in Development of its One-Piece, Needle Free Symphony tCGM Biosensor 3Whitepaper From Mirial Explains how Visual Communication Technology can Improve Healthcare Services 2
(Date:4/23/2014)... Washington State University Spokane have developed a new ... nod off behind the wheel. , Their recently ... are more variable in drowsy driversand offers an ... video-based driver drowsiness detection systems. , Van Dongen"Video-based ... car is drifting out of its lane are ...
(Date:4/23/2014)... Society for Radiation Oncology (ASTRO) has issued a ... for Endometrial Cancer: An ASTRO Evidence-Based Guideline," that ... the treatment of endometrial cancer. The guideline,s executive ... of Practical Radiation Oncology (PRO), the ... guideline is available as an open-access article online ...
(Date:4/23/2014)... pathway that helps prevent new cells from receiving too ... been directly linked to cancer and other diseases. , ... the end of cell division, the enzyme Cdc14 activates ... are fully repaired before the parent cell distributes copies ... safeguard against some of the most devastating genome errors, ...
(Date:4/23/2014)... 2014Men whose testosterone falls below normal levels are more ... and have heart disease and type 2 diabetes. A ... for further testing and possible treatment is described in ... a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. ... of Men,s Health website at http://www.liebertpub.com/jmh . ...
(Date:4/23/2014)... 23, 2014) The American Gastroenterological Association (AGA) ... AGA Research Scholars. The AGA Research Scholar Awards ... develop independent and productive research careers in digestive ... fund an additional year allowing for three consecutive ... supporting junior faculty who are paving the way ...
Breaking Medicine News(10 mins):Health News:WSU innovation improves drowsy driver detection 2Health News:ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer 2Health News:ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer 3Health News:Study identifies enzymes that help fix cancer-causing DNA defects 2Health News:AGA announces 2014 Class of AGA Research Scholars 2
... Scientists have determined how to fortify the cassava ... with enough vitamins, minerals and protein to provide the ... in a single meal. , The researchers have further ... crop,s most damaging viral threats and are refining methods ...
... in Spanish . , The " La Mente ... Faculty of Arts at the University of the Basque Country analyses ... the brain acquires and manages languages and to discover in what ... , In order to understand how we become fluent in ...
... Facts panel makes it tough to make healthy choices, study ... 4 grams of trans fats in a serving of baked or ... , Answer: It,s always unhealthy, since no amount of ... new study suggests that the Nutrition Facts panel found on the ...
... Compliance -, LEXINGTON, Mass., June 30th ... the prestigious Supplier,Performance Award from Premier, Inc. for ... in quality and compliance by,Premier vendors, with less ... presented with the honor at Premier,s 2008 Annual ...
... June 30 Cadient Group, the,premier strategic interactive ... Stephen Wray, President and CEO of Cadient,Group, was ... The Year(R) in the,Greater Philadelphia region. According to ... recognize outstanding entrepreneurs on a regional, national,and global ...
... India, June 30 Sun Pharmaceutical,Industries Ltd. (Reuters: ... announced that Alkaloida Chemical Company Exclusive Group,Ltd. (Alkaloida), ... tender offer,for all outstanding Ordinary Shares of Taro ... in cash., On May 18, 2007, Taro ...
Cached Medicine News:Health News:Fortified cassava could provide a day's nutrition in a single meal 2Health News:Fortified cassava could provide a day's nutrition in a single meal 3Health News:Fortified cassava could provide a day's nutrition in a single meal 4Health News:Laka: 'Language exists in the brain' 2Health News:Laka: 'Language exists in the brain' 3Health News:Laka: 'Language exists in the brain' 4Health News:Trans Fat Labeling Gets Tricky 2Health News:Trans Fat Labeling Gets Tricky 3Health News:Trans Fat Labeling Gets Tricky 4Health News:Trans Fat Labeling Gets Tricky 5Health News:Instrumentation Laboratory Receives Performance Award from Premier for Second Consecutive Year 2Health News:Cadient Group President and CEO, Stephen Wray, Named 2008 Ernst & Young Entrepreneur Of The Year(R) in Greater Philadelphia Region 2Health News:Cadient Group President and CEO, Stephen Wray, Named 2008 Ernst & Young Entrepreneur Of The Year(R) in Greater Philadelphia Region 3Health News:Sun Pharma Commences All Cash Tender Offer to Purchase Taro Ordinary Shares for USD 7.75 Per Share 2Health News:Sun Pharma Commences All Cash Tender Offer to Purchase Taro Ordinary Shares for USD 7.75 Per Share 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: